These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 8627770
21. [Expression of multi-copy and immuno-reactivity of recombinant type-specific epitope of herpes simplex virus type 1]. Ji XW, Mao XH, Zou QM, Yu QT, Zhao LL. Zhonghua Nan Ke Xue; 2006 Jul; 12(7):579-82. PubMed ID: 16894929 [Abstract] [Full Text] [Related]
22. Characterization of human antibody responses to four corners hantavirus infections among patients with hantavirus pulmonary syndrome. Jenison S, Yamada T, Morris C, Anderson B, Torrez-Martinez N, Keller N, Hjelle B. J Virol; 1994 May; 68(5):3000-6. PubMed ID: 7512156 [Abstract] [Full Text] [Related]
23. Detection of human serum antibodies against type-specifically reactive peptides from the N-terminus of glycoprotein B of herpes simplex virus type 1 and type 2 by surface plasmon resonance. Wittekindt C, Fleckenstein B, Wiesmüller K, Eing BR, Kühn JE. J Virol Methods; 2000 Jun; 87(1-2):133-44. PubMed ID: 10856760 [Abstract] [Full Text] [Related]
24. Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein G. Parkes DL, Smith CM, Rose JM, Brandis J, Coates SR. J Clin Microbiol; 1991 Apr; 29(4):778-81. PubMed ID: 1653787 [Abstract] [Full Text] [Related]
25. Expression and characterization of the soluble form of recombinant mature HSV-2 glycoprotein G for use in anti-HSV-2 IgG serodiagnostic immunoassay. Jun W, Hu R, Hyland L, Crandall D, Ramachandran P, Pangarkar C, Sivaraman S, Haghiri B. J Virol Methods; 2018 Feb; 252():65-69. PubMed ID: 29104048 [Abstract] [Full Text] [Related]
26. False-negative type-specific glycoprotein G antibody responses in STI clinic patients with recurrent HSV-1 or HSV-2 DNA positive genital herpes, The Netherlands. van Rooijen MS, Roest W, Hansen G, Kwa D, de Vries HJ. Sex Transm Infect; 2016 Jun; 92(4):257-60. PubMed ID: 26755775 [Abstract] [Full Text] [Related]
27. Repertoire of epitopes recognized by serum IgG from humans vaccinated with herpes simplex virus 2 glycoprotein D. Whitbeck JC, Huang ZY, Cairns TM, Gallagher JR, Lou H, Ponce-de-Leon M, Belshe RB, Eisenberg RJ, Cohen GH. J Virol; 2014 Jul; 88(14):7786-95. PubMed ID: 24789783 [Abstract] [Full Text] [Related]
28. Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2. Eing BR, Lippelt L, Lorentzen EU, Hafezi W, Schlumberger W, Steinhagen K, Kühn JE. J Clin Microbiol; 2002 Feb; 40(2):407-13. PubMed ID: 11825950 [Abstract] [Full Text] [Related]
29. Discrimination of antibody to herpes B virus from antibody to herpes simplex virus types 1 and 2 in human and macaque sera. Fujima A, Ochiai Y, Saito A, Omori Y, Noda A, Kazuyama Y, Shoji H, Tanabayashi K, Ueda F, Yoshikawa Y, Hondo R. J Clin Microbiol; 2008 Jan; 46(1):56-61. PubMed ID: 17989200 [Abstract] [Full Text] [Related]
30. Herpes simplex virus type 2 (HSV-2) IgG index values in two immunoassays in relation to HSV-2 IgG inhibition assay results. Prince HE, Batterman HJ, Schwab DA. Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114864. PubMed ID: 31395403 [Abstract] [Full Text] [Related]
31. Antibodies to epitopes of herpes simplex virus type 1 glycoprotein B (gB) in human sera: analysis of functional gB epitopes defined by inhibition of murine monoclonal antibodies. Sanchez-Pescador L, Pereira L, Charlebois ED, Kohl S. J Infect Dis; 1993 Oct; 168(4):844-53. PubMed ID: 7690824 [Abstract] [Full Text] [Related]
34. Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assay. Burbelo PD, Hoshino Y, Leahy H, Krogmann T, Hornung RL, Iadarola MJ, Cohen JI. Clin Vaccine Immunol; 2009 Mar; 16(3):366-71. PubMed ID: 19129469 [Abstract] [Full Text] [Related]
35. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies. Prince HE, Ernst CE, Hogrefe WR. J Clin Lab Anal; 2000 Mar; 14(1):13-6. PubMed ID: 10645979 [Abstract] [Full Text] [Related]
36. Peptide sequences of glycoprotein G-2 discriminate between herpes simplex virus type 2 (HSV-2) and HSV-1 antibodies. Levi M, Rudén U, Wahren B. Clin Diagn Lab Immunol; 1996 May; 3(3):265-9. PubMed ID: 8705666 [Abstract] [Full Text] [Related]
37. Evaluation of commercial herpes simplex virus IgG and IgM enzyme immunoassays. Liermann K, Schäfler A, Henke A, Sauerbrei A. J Virol Methods; 2014 Apr; 199():29-34. PubMed ID: 24418499 [Abstract] [Full Text] [Related]
38. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. Kuklin N, Daheshia M, Karem K, Manickan E, Rouse BT. J Virol; 1997 Apr; 71(4):3138-45. PubMed ID: 9060677 [Abstract] [Full Text] [Related]
39. Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy. Arvaja M, Lehtinen M, Koskela P, Lappalainen M, Paavonen J, Vesikari T. Sex Transm Infect; 1999 Jun; 75(3):168-71. PubMed ID: 10448394 [Abstract] [Full Text] [Related]
40. Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus. Seyfizadeh N, Kalbermatter D, Imhof T, Ries M, Müller C, Jenner L, Blumenschein E, Yendrzheyevskiy A, Grün F, Moog K, Eckert D, Engel R, Diebolder P, Chami M, Krauss J, Schaller T, Arndt M. J Biomed Sci; 2024 May 28; 31(1):56. PubMed ID: 38807208 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]